This is in contrast to a recent report that single-agent E.coli-derived asparaginase was unable to inhibit PDAC tumor growth, which confirms the value of utilizing a crisantaspase, which targets both asparagine and glutamine [33]. Here, ASPG is linked to neoplasm.